HealthNotableConfirmedDeveloping
9.4
Japan implements structural drug pricing reforms impacting global pharmaceutical margins
Nikkei Asia·JP·about 14 hours ago
Brazilian pharmaceutical company EMS has lowered the price of its OZIVY product to R$ 999 for a three-pen pack to improve patient access. The move aims to increase adherence to long-term treatment regimens, though the specific clinical indications for the drug and the criteria for patient eligibility remain unspecified.